Ginsberg JS - Search Results

1

Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin.

Anand SS, Yusuf S, Pogue J, Ginsberg JS, Hirsh J; Organization to Assess Strategies for Ischemic Syndromes Investigators. Anand SS, et al. Among authors: ginsberg js. Circulation. 2003 Jun 17;107(23):2884-8. doi: 10.1161/01.CIR.0000077530.53367.E9. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796128

2

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.

Anand S, Ginsberg JS, Kearon C, Gent M, Hirsh J. Anand S, et al. Among authors: ginsberg js. Arch Intern Med. 1996 Aug 12-26;156(15):1677-81. Arch Intern Med. 1996. PMID: 8694666

3

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, Haley S, Kearon C, Hirsh J, Gent M. Anand SS, et al. Among authors: ginsberg js. Arch Intern Med. 1999 Sep 27;159(17):2029-32. doi: 10.1001/archinte.159.17.2029. Arch Intern Med. 1999. PMID: 10510988

4

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Eikelboom JW, et al. Among authors: ginsberg js. Lancet. 2000 Jun 3;355(9219):1936-42. doi: 10.1016/S0140-6736(00)02324-2. Lancet. 2000. PMID: 10859038

5

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Bates SM, Greer IA, Hirsh J, Ginsberg JS. Bates SM, et al. Among authors: ginsberg js. Chest. 2004 Sep;126(3 Suppl):627S-644S. doi: 10.1378/chest.126.3_suppl.627S. Chest. 2004. PMID: 15383488 Review.

6

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M; Fixed-Dose Heparin (FIDO) Investigators. Kearon C, et al. Among authors: ginsberg js. JAMA. 2006 Aug 23;296(8):935-42. doi: 10.1001/jama.296.8.935. JAMA. 2006. PMID: 16926353 Clinical Trial.

7

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials.

Vanassche T, Hirsh J, Eikelboom JW, Ginsberg JS. Vanassche T, et al. Among authors: ginsberg js. Thromb Haemost. 2014 Nov;112(5):918-23. doi: 10.1160/TH14-04-0346. Epub 2014 Sep 4. Thromb Haemost. 2014. PMID: 25187203 Review.

8

Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer.

Hirsh J, Ginsberg JS. Hirsh J, et al. Among authors: ginsberg js. N Engl J Med. 2018 Feb 15;378(7):673-674. doi: 10.1056/NEJMe1800041. N Engl J Med. 2018. PMID: 29443673 No abstract available.

9

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.

Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Harrison L, et al. Arch Intern Med. 1998 Oct 12;158(18):2001-3. doi: 10.1001/archinte.158.18.2001. Arch Intern Med. 1998. PMID: 9778199 Clinical Trial.

10

Anticoagulants during pregnancy.

Ginsberg JS, Hirsh J. Ginsberg JS, et al. Annu Rev Med. 1989;40:79-86. doi: 10.1146/annurev.me.40.020189.000455. Annu Rev Med. 1989. PMID: 2658763 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page